Category Archive: Label-free

Oct 30

2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting

Great job by the Nallathamby lab (PDNANO) members Conor, Kevin and Carlie at presenting our work on antibacterials, and cancer therapeutics to the @ND_IPH advisory board! Great input from the advisory board members on possible collaborations and translational paths forward. #GoIrish#NDResearch#MDR#curecancer All three presenters have publications with us which formed the basis for these poster …

Continue reading »

Jan 09

Nallathamby Lab at the Society for Biomaterials/ Japanese Society for Biomaterials (Jan 8-10, 2022) Hawaii

Virtually presented our lab’s research on tackling two pressing problems in biomedical research at the Society for Biomaterials/ Japanese Society for Biomaterials joint Symposium in Honolulu, Hawaii.  (January 8-10, 2022). I am presenting our research on broad-spectrum antibiotic-free antibacterials to combat multi-drug resistant bacterial infections. Oral Presentation Session:  Session 1: Bioglasses/Ceramics/Other Hard Materials2:37 – 2:52 …

Continue reading »

Jun 20

ACS-Institutional Research Grant -Phase II Grant Funded to Mitigate Cardiotoxicity of Chemotherapeutics using our Nanocarriers

Excited that our phase-II proposal to the American Cancer Society’s Institutional Research Grant (ACS-IRG) program was funded. This was upon successful phase I completion of our proposal for a novel magnetically driven drug nanocarrier. We propose to use these drug nanocarriers to mitigate cardiotoxicity in the new study. The data generated by the study funded …

Continue reading »

Feb 14

American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo

We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …

Continue reading »